Neuberger Berman Group LLC Assembly Biosciences, Inc. Transaction History

Neuberger Berman Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$12.9 - $20.8 $167,700 - $270,400	-13,000 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$17.7 - $24.93 $230,100 - $324,090	13,000 New	13,000 $256,000
Q1 2018 May 08, 2018	SELL	$41.7 - $64.16 $229,350 - $352,880	-5,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $157,190 - $274,505	5,500	5,500 $249,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.